Posts Tagged ‘diagnostic’

Aarkstore Enterprise-Womens Health Diagnostic Testing

Table of Contents : 
1.0 Overview 7
1.1 Statement of Report 7
1.2 Scope of this Report 7
1.3 Methodology 8
1.4 Executive Summary 9

2.0 Introduction – Sector Overview 11
2.1 Global Diagnostic Products Industry 11

3.0 Women’s Health Testing Market Analysis in Size, Growth and Share 13
3.1 Global Women’s Health Testing Markets 13
3.1.1 Market Drivers in the Women’s Health Diagnostics Testing Sector 13
3.1.1.1 Market Segments for Women’s Health Testing 13
3.1.1.2 Key Players in the Women’s Health Diagnostics Testing Segment 14
3.1.1.3 Women’s Health Testing Sector Analysis 15
3.2 U.S. Women’s Health Testing Market 15
3.2.1 Market Overview 15
3.2.2 Diagnostic Test Categories 16
3.3 European Women’s Health Diagnostic Test Market 17
3.3.1 German Women’s Care Diagnostic Market 19
3.3.2 U.K. Women’s Care Testing Diagnostic Market 22
3.3.2.1 U.K. Market Statistics 22
3.3.2.2 U.K. Competitive Analysis 23
3.3.2.3 U.K. Market Access 24
3.3.3 French Women’s Care Diagnostic Market 25
3.3.4 Italian Women’s Care Diagnostic Market 25
3.3.5 Spanish Women’s Care Diagnostic Market 26
3.4 Japanese Women’s Care Testing Market 26
3.5 Chinese Women’s Care Market 27
3.6 Rest of the World Women’s Care Testing Market 28

4.0 Women’s Health Testing Individual Markets 30
4.1 Pregnancy Testing 30
4.2 Osteoporosis Testing 36
4.2.1 In Vitro Blood Tests 40
4.2.2 Bone Densitometry Devices 42
4.3 Prenatal Screening Testing 44
4.3.1 Cystic Fibrosis 44
4.3.2 Prenatal Genetic Testing 47
4.3.3 Fragile X Syndrome 49
4.3.4 Tay-Sachs Disease 49
4.4 Fertility Testing 49
4.5 Breast Cancer 52
4.5.1 CA 15-3 54
4.5.2 CA 27-29 54
4.5.3 BRCA1 Breast and Ovarian Cancer Gene 54
4.5.4 BRCA2 Breast Cancer Gene 54
4.5.5 Tissue polypeptide antigen (TPA) 56
4.5.6 DNA Ploidy and S-phase Fraction 56
4.5.7 Estrogen and Progesterone Receptor (ER and PR) 56
4.5.8 HER-2 56
4.5.9 HER-2 and Herceptin 57
4.5.10 p53 57
4.5.11 NMP66 57
4.5.12 Mammastatin 57
4.6 Ovarian Cancer 58
4.6.1 CA 125 II™ 58
4.6.2 Steroid Hormone Receptors 60
4.6.3 Epidermal Growth Factor Receptor (EGFR) 60
4.6.4 HER-2/neu 60
4.6.5 P53 Tumor Suppressor Gene 60
4.6.6 Lysophospholipids 60
4.7 Cervical Cancer 61
4.7.1 Pap Smears 62
4.7.2 Human Papillomavirus (HPV) Testing 65
4.8 Miscellaneous Testing 69
4.8.1 Estriol 69
4.8.2 Fetal Fibronectin (fFN) 70
4.8.3 Vaginal pH and Vaginitis 70
4.9 Human Immunodeficiency Virus (HIV) 71
4.10 Infectious Disease Testing 72
4.10.1 Strep Testing 72
4.10.2 Chlamydia 75
4.10.3 Methicillin-Resistant Staphylococcus Aurea (MRSA) 76
4.10.4 Hepatitis 77

For more information please contact :

http://www.aarkstore.com/reports/Womens-Health-Diagnostic-Testing-1340.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise
Contact: Neel
Email: press@aarkstore.com
http://www.aarkstore.com

Novartis, Myriad May Get Shield for Diagnostic Tests After High Court Case

Novartis, Myriad May Get Shield for Diagnostic Tests After High Court Case
Myriad Genetics Inc. , Genomic Health Inc. and the rest of the burgeoning industry for personalized medicine stand to gain from yesterday’s landmark U.S. Supreme Court decision on patenting business methods.

Read more on Bloomberg

Why the diagnostic for breast cancer is poor, and doctors don’t refer to right tests and don’t listen?

I have dence breast, i had discharge from breast before, and my sister had cancer.Doctors in Kaizer Permanente San Francisco didn’t refer me for diagnostic mammogram or ultrasound, only for regular mammogram.I had mam. in 2004, 2005,2006.They found differens in mm.2006 komparing 2004.
It mean, i already had cancer in 2005, but they missed it.
I had biopcy, and it was taken from 2 places.
and they have to put them in two different containers, but they puted them in one.The tecnition said, it is first time in his career.And i had to have one more biopcy.
Based on result, one MD.said, i have breast cancer, 2 tumors, another said, i have only one tumor. Surgeon said, he will cut out one tumor, because second is not tumor.I was begging him to take out both, and hi did it.The second one turn out was a tumor, too.Surgeon said it happen first time in his career.And i had second surgery for second tumor.I had one unnesessery biopcy and one unnessesery surgery. Doctors should pay attention

Breast Cancer: Screening vs. Diagnostic Mammograms

What’s the difference between a screening and diagnostic mammogram? View the videos in the www.healthchoices.ca medical video library, featuring Dr Ian Gardiner, Director of Advanced Breast Imaging Program at Canada Diagnostic Centres in Vancouver,

I have two lumps on my right breast. Went to doctor and will have a diagnostic mammogram done but in 5 weeks?

I am 32 and the next available appointment at the hospital i have the order to go to is not until May 18. Isn’t that too long away? I am high risk for breast cancer, my mother was diagnosed with breast cancer at 42 and died at 52. I also have pain in the chest area. I am very worried, what if my time is running out to catch this at an early stage.